THE ROLE OF APOPTOTIC MOLECULES IN HERPETIC STROMAL
THE ROLE OF APOPTOTIC MOLECULES IN HERPETIC STROMAL
批准号:
7935224
负责人:
Patrick M Stuart
金额:
$34.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2012-09-29
关键词:
ApoptosisApoptoticBlindnessCellsCessation of lifeCicatrixCommunicable DiseasesCorneaCorneal DiseasesCountryDataDevelopmentDiseaseEyeEye diseasesGenesGenomeGrowthHerpesvirus 1Herpetic KeratitisHumanImmuneInbred BALB C MiceIncidenceInfectionInflammationInflammatory ResponseKeratitisKeratoplastyLaboratoriesLeadLuciferasesLymphoid CellMaintenanceManuscriptsMediatingModelingMonitorMouse StrainsMusMutant Strains MiceMutationNervous system structureNeuronsPeripheralPlayPreventionPublishingRecurrenceRegulatory T-LymphocyteReportingRoleSimplexvirusStructure of trigeminal ganglionT-LymphocyteTNFRSF6 geneTestingTissuesTumor Necrosis Factor Ligand Superfamily Member 6United StatesViralVirusVirus DiseasesVirus LatencyVirus SheddingWild Type MouseWorkcell typecorneal allograftdesigndisease phenotypeirradiationmacrophagemutantneovascularizationneuropathologyneutrophilocular surfacepreventpublic health relevancesuccesstrafficking
中文摘要
描述(由申请人提供):我们的实验室一直在研究Fas和Fas配体在角膜移植中的作用,并发表了几篇论文,详细介绍了这种相互作用对角膜同种异体移植成功和预防角膜新生血管形成的重要性。然而,这些凋亡分子在疱疹性眼病中的作用仍有待充分阐明。关于该主题的唯一报告使用了不会产生显著疾病的病毒-小鼠品系组合。因此,凋亡分子在引起或预防HSV-1介导的眼部疾病中的确切作用尚不清楚。为了使这种情况更加清楚,我们进行了初步研究,其中我们用HSV-1的科斯株感染BALB/c、BALB-lpr(Fas突变体)和BALB-gld(Fas配体突变体)小鼠,以及用HSV-1的McKrae株感染C57 BL/6及其突变体,并监测角膜疾病和病毒从眼表面的脱落。我们的观察表明,表达Fas(CD 95)基因突变的小鼠比野生型BALB/c或B6小鼠具有显著更差的HSK和眼周疾病。这些小鼠品系的Gld突变体与野生型(BALB/c)没有不同,或显示中间疾病表型。初步结果还表明,与野生型对照相比,病毒在BALB-lpr小鼠的外周组织中可能持续时间稍长,但在BALB-gld小鼠中也观察到类似的持续性。这表明lpr小鼠的疾病表型可能不仅仅是由于病毒的持续存在,还涉及其他机制。为了更好地确定细胞凋亡分子在疱疹性角膜基质炎中的作用,我们提出:确定Fas和FasL对眼部疾病的具体贡献,防止神经病理学,病毒生长和维持病毒潜伏期。其次,由于我们知道复发性眼病与原发性HSK不同,我们将在HSK复发模型中进行类似的研究,以评估Fas和FasL在这种疾病中的作用。我们还将探索用可溶性形式的Fas配体治疗小鼠作为更有效地控制HSV-1引发的炎症的手段的功效。我们相信这些研究将使我们能够更好地了解Fas-Fas配体相互作用在角膜感染性疾病中的作用。本申请中的研究旨在更好地了解单纯疱疹病毒感染后控制免疫细胞(炎症)进入角膜的机制。这一点很重要,因为发生的炎症越多,对角膜的损害就越严重。此外,我们将测试一种潜在的治疗方法,旨在进一步控制和预防炎症。
英文摘要
DESCRIPTION (provided by applicant): Our laboratory has been studying the role that Fas and Fas ligand play in corneal transplantation and have published several manuscripts detailing the importance of this interaction to the success of corneal allografts and the prevention of neovascularization of the cornea. However, the role that these apoptotic molecules play in herpetic eye disease remains to be fully delineated. The only report on this subject used a virus-mouse strain combination that does not produce significant disease. Thus the precise role that apoptotic molecules play in either causing or preventing HSV-1-mediated ocular disease is not clear. In order to bring more clarity to this situation, we performed preliminary studies wherein we infected BALB/c, and BALB-lpr (Fas mutants), and BALB-gld (Fas Ligand mutants) mice with the KOS strain of HSV-1 as well as C57BL/6 and its mutants with the McKrae strain of HSV-1, and monitored both corneal disease and shedding of virus from the ocular surface. Our observations indicate that mice that express a mutation in the Fas (CD95) gene had significantly worse HSK, and periocular disease, than did either wild type BALB/c or B6 mice. Gld mutants of these mouse strains were either no different than wild-type (BALB/c) or displayed an intermediated disease phenotype. Preliminary results also suggest that virus might persist in peripheral tissues slightly longer in BALB-lpr mice than in wild type controls, but similar persistence is also noted in BALB-gld mice. Suggesting that the disease phenotype in lpr mice might is not simply due to viral persistence, but that other mechanisms are involved. In order to better define the role that apoptotic molecules have during herpetic stromal keratitis we propose: To determine the specific contributions of Fas and FasL to ocular disease, protection from neuropathology, growth of virus, and maintenance of viral latency. Secondly, since we know that recurrent eye disease is not the same as primary HSK, we will perform similar studies in a recurrent model of HSK to evaluate the role of Fas and FasL in this form of the disease. We will also explore the efficacy of treating mice with a soluble form of Fas ligand as a means of more effectively controlling HSV-1 initiated inflammation. We believe these studies will enable us to better understand the role that the Fas-Fas ligand interaction plays during infectious disease of the cornea. PUBLIC HEALTH RELEVANCE The studies in this application are designed to better understand what mechanisms are involved in controlling the entry of immune cells (inflammation) into the cornea following infection with herpes simplex virus. This is important because the more inflammation that occurs the worse will be damage to the cornea. In addition, we will test a potential therapy that is designed to further control and possibly prevent inflammation.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Therapeutic Use of Soluble Fas Ligand Ameliorates Acute and Recurrent Herpetic Stromal Keratitis in Mice.
可溶性 Fas 配体的治疗用途可改善小鼠急性和复发性疱疹性基质角膜炎。
DOI:
10.1167/iovs.15-16588
发表时间:
2015
期刊:
Investigative ophthalmology & visual science
影响因子:
4.4
作者:
[Rogge,Megan, Yin,Xiao-Tang, Godfrey,Lisa, Lakireddy,Priya, Potter,ChloeA, DelRosso,ChelseaR, Stuart,PatrickM]
通讯作者:
Stuart,PatrickM
Mechanisms of HSK amelioration
-
批准号:8389553
-
项目类别:
-
资助金额:$35.63万
-
财政年份:2011
-
负责人:Patrick M Stuart
-
依托单位:
Mechanisms of HSK amelioration
-
批准号:8597431
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2011
-
负责人:Patrick M Stuart
-
依托单位:
Mechanisms of HSK amelioration
-
批准号:8026561
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2011
-
负责人:Patrick M Stuart
-
依托单位:
Mechanisms of HSK amelioration
-
批准号:8207849
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2011
-
负责人:Patrick M Stuart
-
依托单位:
THE ROLE OF APOPTOTIC MOLECULES IN HERPETIC STROMAL
-
批准号:7526460
-
项目类别:
-
资助金额:$35.3万
-
财政年份:2009
-
负责人:Patrick M Stuart
-
依托单位:
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION
-
批准号:6384835
-
项目类别:
-
资助金额:$32.37万
-
财政年份:1999
-
负责人:Patrick M Stuart
-
依托单位:
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION
-
批准号:2899161
-
项目类别:
-
资助金额:$27.25万
-
财政年份:1999
-
负责人:Patrick M Stuart
-
依托单位:
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION
-
批准号:6179299
-
项目类别:
-
资助金额:$26.94万
-
财政年份:1999
-
负责人:Patrick M Stuart
-
依托单位:
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION
-
批准号:6951737
-
项目类别:
-
资助金额:$5.36万
-
财政年份:1999
-
负责人:Patrick M Stuart
-
依托单位:
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION
-
批准号:6414277
-
项目类别:
-
资助金额:$6.49万
-
财政年份:1999
-
负责人:Patrick M Stuart
-
依托单位:
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION
-
批准号:6524983
-
项目类别:
-
资助金额:$33.2万
-
财政年份:1999
-
负责人:Patrick M Stuart
-
依托单位:
FAS L INDUCED APOPTOSIS IN CORNEA TRANSPLANTATION
-
批准号:6637194
-
项目类别:
-
资助金额:$29.44万
-
财政年份:1999
-
负责人:Patrick M Stuart
-
依托单位:
AMELIORATION OF RECURRENT HERPES KERATITIS
-
批准号:6384708
-
项目类别:
-
资助金额:$22.92万
-
财政年份:1998
-
负责人:Patrick M Stuart
-
依托单位:
Amelioration of recurrent herpes keratitis
-
批准号:6617615
-
项目类别:
-
资助金额:$37.08万
-
财政年份:1998
-
负责人:Patrick M Stuart
-
依托单位:
Amelioration of recurrent herpes keratitis
-
批准号:6751542
-
项目类别:
-
资助金额:$36.12万
-
财政年份:1998
-
负责人:Patrick M Stuart
-
依托单位:
Amelioration of recurrent herpes keratitis
-
批准号:6895084
-
项目类别:
-
资助金额:$37.31万
-
财政年份:1998
-
负责人:Patrick M Stuart
-
依托单位:
Amelioration of recurrent herpes keratitis
-
批准号:7233139
-
项目类别:
-
资助金额:$38.64万
-
财政年份:1998
-
负责人:Patrick M Stuart
-
依托单位:
Amelioration of recurrent herpes keratitis
-
批准号:7059913
-
项目类别:
-
资助金额:$37.63万
-
财政年份:1998
-
负责人:Patrick M Stuart
-
依托单位:
AMELIORATION OF RECURRENT HERPES KERATITIS
-
批准号:6179213
-
项目类别:
-
资助金额:$22.41万
-
财政年份:1998
-
负责人:Patrick M Stuart
-
依托单位:
IA INDUCTION/EXPRES'N IN NON-BONE MARROW-DERIVED CELLS
-
批准号:3029218
-
项目类别:
-
资助金额:$2.93万
-
财政年份:1989
-
负责人:Patrick M Stuart
-
依托单位:
海外基金